Fox Chase Cancer Center Welcomes Dr. Michael Seidman

Michael Seidman, MD

Fox Chase Cancer Center is pleased to announce the hiring of Michael Seidman, MD, as a Professor in the Department of Hematology/Oncology.

Seidman is joining Fox Chase after spending over 15 years at Alliance Cancer Specialists in Horsham, Pennsylvania, where he provided care to patients with a wide array of hematologic and oncologic disorders, assisted in the development of a new radiation oncology center, and participated in clinical trials. He also served as a board member of Alliance Cancer Specialists and managing partner of the Abington Division.

He was also on the medical staff of Chestnut Hill Hospital, Holy Redeemer Medical Center, and Jefferson Abington Hospital. Seidman also served on the Cancer Committee for Holy Redeemer and Jefferson Abington, where he was a member of the Medical Executive Committee. He has been listed as a Top Doctor in oncology by Philadelphia magazine from 2020 through 2023.

Seidman received his medical degree from the Lewis Katz School of Medicine at Temple University. He completed an internal medicine residency at Temple University Hospital, followed by an oncology fellowship at New York University Medical Center. While at NYU, he was named Hematology/Oncology Chief Fellow and Oncology Fellow of the Year.

Seidman has a number of professional publications and presentations to his credit, and some of his presentations were delivered in Barcelona at the First World Meeting of Interdisciplinary Melanoma Centers. He is board certified in hematology and medical oncology.

Seidman began his tenure at Fox Chase on August 4, 2024.